Jaguar Health Reports Q3 2025 Earnings with Sequential Revenue Growth
Jaguar Health (NASDAQ: JAGX) reported combined net revenue of $3.1 million in Q3 2025, showing a sequential increase from the previous quarter and flat year-over-year performance. The company also noted a narrowing net loss to $9.5 million compared to fiscal Q3 2024.
Topics: clinical data ebitda net loss revenue